Fulcrum Therapeutics (FULC) Ownership - Who Owns Fulcrum Therapeutics?

521 Followers

Fulcrum Therapeutics (FULC) Ownership Overview

10.23% Insiders

8.17% Mutual Funds

58.96% Other Institutional Investors

11.58% ETFs

11.07% Public Companies and

Individual Investors

The ownership structure of Fulcrum Therapeutics (FULC) stock is a mix of institutional, retail, and individual investors. Approximately 78.70% of the company’s stock is owned by Institutional Investors, 10.23% is owned by Insiders, and 11.07% is owned by Public Companies and Individual Investors.

The ownership structure of Fulcrum Therapeutics (FULC) stock is a mix of institutional, retail, and individual investors. Approximately 67.13% of the company’s stock is owned by Institutional Investors, 10.23% is owned by Insiders, and 11.58% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date	Name	Activity	Value
Dec 10, 2025	Ra Capital Management, Llc	xxxxxxxxxxxxx	$58377021

Show More Insider Trading Activity >

Recent Hedge Fund Trading Activity

Date	Firm	Activity	Value
Mar 31, 2024	Graham Capital Management, L.p.	xxxxxxxxxxxxx	$327823
Mar 31, 2024	Entrypoint Capital, Llc	xxxxxxxxxxxxx	$347052

Show More Hedge Fund Trading Activity >

Top Shareholders

Holder	# of Shares	Type	% Holding	Value
Peter Kolchinsky	6,053,960	Institution	9.09%	22,399,652
	6,053,960	Insider	9.09%	22,399,652
	3,191,836	Institution	4.79%	11,809,793
	2,715,911	Institution	4.08%	10,048,871
	2,623,099	Institution	3.94%	9,705,466
	619,986	Institution	0.93%	2,293,948
	546,953	Institution	0.82%	2,023,726
	494,517	Institution	0.74%	1,829,713
	487,018	Institution	0.73%	1,801,967
	454,864	Insider	0.68%	1,682,997

Top Mutual Fund Holders

# of Shares	Type	% Holding	Value
2,623,099	Institution	3.94%	9,705,466
619,986	Institution	0.93%	2,293,948
546,953	Institution	0.82%	2,023,726
487,018	Institution	0.73%	1,801,967
248,886	Institution	0.37%	920,878
167,215	Institution	0.25%	618,696
128,111	Institution	0.19%	474,011
113,751	Institution	0.17%	420,879
111,403	Institution	0.17%	412,191
53,570	Institution	0.08%	198,209

Top ETF Holders

Holder	# of Shares	Type	% Holding	Value
Vanguard Total Stock Market ETF	2,074,332	Institution	3.11%	14,354,377
iShares Russell 2000 ETF	1,419,931	Institution	2.13%	5,353,140
Vanguard Extended Market ETF	552,894	Institution	0.83%	3,826,026
iShares Russell 2000 Value ETF	470,264	Institution	0.71%	1,772,895
iShares Biotechnology ETF	389,752	Institution	0.58%	1,469,365
SPDR S&P Pharmaceuticals ETF	388,327	Institution	0.58%	1,436,810
Vanguard Russell 2000 ETF	308,051	Institution	0.46%	2,131,713
Schwab U.S. Small-Cap ETF	228,686	Institution	0.34%	846,138
U.S. Micro Cap Portfolio ETF	188,653	Institution	0.28%	1,446,969
iShares Micro-Cap ETF	154,478	Institution	0.23%	582,382

FAQ

Who Owns Fulcrum Therapeutics (FULC)?

According to the latest TipRanks data, approximately 58.96% of the company's stock is held by institutional investors, 10.23% is held by insiders, and 11.07% is held by retail investors.

What percentage of Fulcrum Therapeutics (FULC) stock is held by institutional investors?

According to the latest TipRanks data, approximately 58.96% of Fulcrum Therapeutics (FULC) stock is held by institutional investors.

What percentage of Fulcrum Therapeutics (FULC) stock is held by retail investors?

According to the latest TipRanks data, approximately 11.07% of Fulcrum Therapeutics (FULC) stock is held by retail investors.

Who owns the most shares of Fulcrum Therapeutics (FULC)?

Peter Kolchinsky owns the most shares of Fulcrum Therapeutics (FULC).

What is the significance of the ownership structure for a publicly traded company?

The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.